Mersana Therapeutics buy BTIG Research
Start price
29.02.24
/
50%
€5.00
Target price
28.02.25
€5.54
Performance (%)
-56.96%
Price
30.05.24
€2.15
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Mersana Therapeutics is performing very badly with a performance of -56.96%. This prediction currently runs until 28.02.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Mersana Therapeutics | -1.825% | -1.825% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by BTIG_Research for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $6.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat